Turbine was founded on the premise that a predictive computational model of biology will revolutionize drug development. Turbine builds a platform to understand the inner mechanisms of cancer enabling the discovery of novel protein targets, precision biomarkers and better translation to patients. Based on a decade of research and utilizing a plethora of available data within molecular biology literature, Turbine has built a mechanistic and predictive computational model of human cells. This platform is fully customizable with multiomics data and protein-protein interaction measurements which can be used to indicate potential drug targets, or even deliver customised treatment to a single patient.